The study evaluates the efficiency, in terms of quality of life improvement, of a patient's therapeutic education program (ETP), based on long term commitment in adapted physical activities carried out during a standardized thermal cure (CTS) for fibromyalgia among patients continuing regular drug treatment or not
Fibromyalgia is a poorly known and understood disease. Patients suffer from pain, fatigue, sleep disorders, anxiety, depression, preventing them from moving and going out, resulting in an alteration of social life. Multiple drugs treatment is frequently used but is burdensome and poorly effective. However, thermal cure proved efficacious to improve quality of life during the cure and beyond. This study aims at demonstrating the added value of a patient's therapeutic education program provided during a thermal cure, a moment where patients are available and receptive to guidance.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
152
OTD
Dax, Aquitaine, France
Change in quality of life
Change from baseline in quality of life assessed through the self-administered Fibromyalgia Impact Questionnaire (FIQ) month 06 after cure completion.
Time frame: Month 06 after cure completion
Change in quality of life
Average change from baseline in pain intensity measured on a Visual Analogical Scale (VAS)
Time frame: Week 03, Month 03, Month 12
Responder rate
Rate of patients responding to intervention, i.e. with FIQ score increased from at least 14% as compared to Day 00
Time frame: Week 03, Month 03, Month 06, Month 12
Pain intensity
Average change from baseline in pain intensity measured on a Visual Analogical Scale (VAS)
Time frame: Week 03, Month 03, Month 06, Month 12
Pain relief
Average change from baseline in pain relief measured on a VAS
Time frame: Week 03, Month 03, Month 06, Month 12
Kinesiophobia index
Average change from baseline in kinesiophobia measured by TAMPA scale
Time frame: Week 03, Month 03, Month 06, Month 12
Catastrophizing index
Average change from baseline in catastrophizing measured by pain catastrophizing scale (PCS)
Time frame: Week 03, Month 03, Month 06, Month 12
Function impairment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Average change from baseline in function impairment measured by the Western Ontario and McMaster Universities Arthritis (WOMAC) scale
Time frame: Week 03, Month 03, Month 06, Month 12
Fatigue
Average change from baseline in fatigue measured by Picot scale
Time frame: Week 03, Month 03, Month 06, Month 12
Somnolence
Average change from baseline in somnolence measured by Epworth scale
Time frame: Week 03, Month 03, Month 06, Month 12
Anxiety and depression
Average change from baseline in anxiety and depression measured by Hospital Anxiety and Average change from baseline in anxiety and depression measured by Hospital ANxiety and Depression scale
Time frame: Week 03, Month 03, Month 06, Month 12
Serious adverse reactions (SARs)
Probability of occurrence of SARs
Time frame: Day 00 to Month 12
drug consumption
change in drug consumption
Time frame: Day 00, Week 03, Month 03, Month 06, Month 12
non-drug treatment consumption
change in non-drug treatment consumption
Time frame: Day 00, Week 03, Month 03, Month 06, Month 12
Thermal outbreaks
Probability of occurrence of thermal outbreaks during the cure period
Time frame: Day 00 to Week 03
Fibromyalgia outbreaks
Probability of occurrence fibromyalgia outbreaks during remote follow-up
Time frame: Week 03 to Month 12